Management tracks: Gottlieb re-joining NEA; plus Seattle Genetics, Celsius and more
Former FDA Commissioner Scott Gottlieb is joining New Enterprise Associates as a special partner. Gottlieb was a venture partner at the firm from 2007 to 2017. In his new role, Gottlieb will have a “deeper role, doing more active investing,” than he had in his previous stint at NEA, Gottlieb told BioCentury. Gottlieb said he will retain his position as a resident scholar at the American Enterprise Institute, a free-market oriented think tank.
Antibody-drug conjugate company Seattle Genetics Inc. (NASDAQ:SGEN) hired Robin Taylor as its first chief commercial officer. He spent almost 18 years at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) before he joined AstraZeneca plc (LSE:AZN; NYSE:AZN) as VP, immuno-oncology franchise head in November 2018...